People

Alita Miller

ArrePath chief scientific officer leading scientific strategy and drug discovery programs. Previously held R&D leadership roles at Entasis Therapeutics and Design Therapeutics, and worked at AstraZeneca, Pfizer, Merck and Eli Lilly. Earned a PhD in biochemistry and molecular biology from the University of Chicago.